GPR55 and cancer: GPR55 is expressed in several peripheral organs, such as the gastrointestinal tract [13], pancreas [14], bone tissue [3], vascular endothelial cells [15] and immune system [16], representing a novel therapeutic target for the treatment of diabetes [14], osteoporosis [3] and cancer [17,18].